EVOTAZ 300 mg/1
atazanavir and cobicistat · TABLET · E.R. Squibb & Sons, L.L.C.
No Recall History
Plain English
EVOTAZ is a tablet containing atazanavir and cobicistat at 300 mg/1, taken oral. Manufactured by E.R. Squibb & Sons, L.L.C..
Key Facts
- Brand Name
- EVOTAZ
- Generic Name
- atazanavir and cobicistat
- NDC Code (Product)
0003-3641- Manufacturer
- E.R. Squibb & Sons, L.L.C.
- Strength
- 300 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA206353
- Drug Class
- Cytochrome P450 3A Inhibitor [EPC]
- Marketing Start
- 01/29/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is EVOTAZ used for?
EVOTAZ contains atazanavir and cobicistat. It is a tablet taken oral. Consult your doctor for specific uses.
Is EVOTAZ a controlled substance?
EVOTAZ is not classified as a controlled substance by the DEA.
What is the generic name for EVOTAZ?
The generic name for EVOTAZ is atazanavir and cobicistat. There are no other listed brand versions of atazanavir and cobicistat.
What is the NDC code for EVOTAZ 300 mg/1?
The NDC (National Drug Code) for EVOTAZ 300 mg/1 is 0003-3641, listed by E.R. Squibb & Sons, L.L.C..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)